Clinical TrialClinical Trial
Title rated 0 out of 5 stars, based on 0 ratings(0 ratings)
Book, 2000
Current format, Book, 2000, 1st ed, Available .Book, 2000
Current format, Book, 2000, 1st ed, Available . Offered in 0 more formatsIn order to combat a deadly hantavirus that has already killed hundreds of Native Americans, Dr. Isabel McLain reluctantly agrees to test a dubious new vaccine on a community of Blackfeet Indians on a reservation in Browning, Montana.
In order to combat a deadly hantavirus that has already killed hundreds of Native Americans, Dr. Isabel McLain must reluctantly agree to test a dubious new vaccine on a community of Blackfeet Indians on a reservation in Browning, Montana. 25,000 first printing.
The deadly hantavirus has killed hundreds of Native Americans, so when a reputable pharmaceutical company claims to have developed a vaccine against the deadly disease, it should be good news. But when ImmuVac asks Dr. Isabel McLain to conduct a clinical trial of the vaccine on the Blackfeet reservation in Browning, Montana, the proposal gets a distinctly mixed response from both her and the suspicious Blackfeet. Is the new drug truly safe, or are the Blackfeet being used as human guinea pigs?
Indian activist Monty Four Bear fears the worst, but Dr. McLain stakes her reputation on the trial's safety. Having taken over the poorly-funded reservation clinic after the catastrophic failure of her marriage, Isabel has fought a long, hard struggle to gain the trust of the wary Blackfeet residents of the reservation. She knows she risks everything she's accomplished by endorsing ImmuVac's clinical trial, but she's willing to take that chance if it means developing a weapon against the hantavirus.
But when corporate greed makes for questionable science, whom can Isabel truly trust with her life and her career --and the lives of the Blackfeet?
In order to combat a deadly hantavirus that has already killed hundreds of Native Americans, Dr. Isabel McLain must reluctantly agree to test a dubious new vaccine on a community of Blackfeet Indians on a reservation in Browning, Montana. 25,000 first printing.
The deadly hantavirus has killed hundreds of Native Americans, so when a reputable pharmaceutical company claims to have developed a vaccine against the deadly disease, it should be good news. But when ImmuVac asks Dr. Isabel McLain to conduct a clinical trial of the vaccine on the Blackfeet reservation in Browning, Montana, the proposal gets a distinctly mixed response from both her and the suspicious Blackfeet. Is the new drug truly safe, or are the Blackfeet being used as human guinea pigs?
Indian activist Monty Four Bear fears the worst, but Dr. McLain stakes her reputation on the trial's safety. Having taken over the poorly-funded reservation clinic after the catastrophic failure of her marriage, Isabel has fought a long, hard struggle to gain the trust of the wary Blackfeet residents of the reservation. She knows she risks everything she's accomplished by endorsing ImmuVac's clinical trial, but she's willing to take that chance if it means developing a weapon against the hantavirus.
But when corporate greed makes for questionable science, whom can Isabel truly trust with her life and her career --and the lives of the Blackfeet?
Title availability
Find this title on
LINK+About
Opinion
More from the community
Community lists featuring this title
There are no community lists featuring this title
Community contributions
There are no quotations from this title
There are no quotations from this title
From the community